Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 105 results found. Search for [ SII vaccine DCGI ]

Results 1 to 21 of 105
Reuters
April 16, 2021
Facing soaring cases and overflowing hospitals after lockdown restrictions were eased, it also abruptly changed the rules to allow it to fast-track vaccine imports, having earlier rebuffed foreign drugmakers like Pfizer


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


BusinessToday.In
March 31, 2021
The Drug Controller General of India (DCGI) has allowed the extension of AstraZeneca coronavirus vaccine's expiration time period from the earlier prescribed six months


BusinessToday.In
March 11, 2021
Price reduction may unlikely have any impact on final price charged from people vaccinating at private hospitals as Covid-19 vaccines are already subsidised by Centre


BusinessToday.In
February 4, 2021
The Union Health Ministry has claimed that India has become the fastest country in the world to reach the 4 million vaccination mark in 18 days


PTI
February 2, 2021
Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines


BusinessToday.In
January 30, 2021
Serum Institute of India CEO Adar Poonawalla said the company's tie-up with American vaccine developer Novavax has published 'excellent efficacy results'


BusinessToday.In
January 21, 2021
The blaze was reported at an under-construction building in the Manjri area of the city. The Serum Institute of India's plant is spread over 100 acres in Pune


BusinessToday.In
January 14, 2021
Company shall be liable for all adversities as per CDSCO/Drugs and Cosmetics Act/DCGI policy/approval, says government's purchase order with vaccine makers


BusinessToday.In
January 7, 2021
COVID-19 vaccination drive: This development comes after the government said that the vaccine would be rolled out 10 days after the date of approval for emergency use


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


BusinessToday.In
January 4, 2021
Both the vaccines got approval for emergency use authorisation on Sunday. They're both administered in two doses, the DCGI said in the permission letter


BusinessToday.In
January 4, 2021
In line with positive global equities, Sensex ended 307 points higher at 48,176 and Nifty gained 114 points to 14,132. During today's session, Sensex hit a lifetime high of 48,220 and Nifty rose to a new high of 14,147


BusinessToday.In
January 4, 2021
Cadila Healthcare share touched an intraday high of Rs 492.95, rising 3.02% against previous close of Rs 478.50 on BSE


BusinessToday.In
January 4, 2021
Wearing a face mask is also crucial in India's fight against coronavirus because the government plans to inoculate 30 crore priority population over the next two months


BusinessToday.In
January 4, 2021
The phase-2 trials of Zydus Cadila's coronavirus vaccine had been conducted in around 1,000 healthy adults


Reuters
January 3, 2021
India on Sunday granted emergency approval to Bharat Biotech's COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine


BusinessToday.In
January 3, 2021
Two leading vaccine contenders in India have been granted approval for restricted use in the country. Check out how netizens reacted to the news of the vaccines getting approved


BusinessToday.In
January 3, 2021
PM Modi thanked doctors, medical staff, police personnel, sanitation workers and all corona warriors for their hard work during the coronavirus outbreak


BusinessToday.In
January 2, 2021
Covishield DCGI approval: Pune-based Serum Institute will have to provide safety, efficacy and immunogenicity data from the ongoing clinical trials in India and globally


PAGES 1 OF 6  12345